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To the Editor: West Nile virus 
(WNV) is a single-stranded RNA 
virus in the family Flaviviridae that is 
transmitted to humans by mosquitoes. 
Approximately 80% of WNV 
infections in humans are asymptomatic, 
whereas ≈20% of infected persons 
experience fever, often accompanied 
by a rash. Less than 1% of infections 
are manifested as neuroinvasive 
disease, such as meningoencephalitis, 
polyradiculoneuritis, and polio-
like fl accid paralysis (1). WNV is 
endemic in Africa, southern Asia, 
and northern Australia, and only 
sporadic cases or small epidemics are 
seen in Europe (2). In 1999, WNV 
emerged in North America. By 2010, 
≈1.8 million persons had become 
infected, with 12,852 reported cases 
of meningoencephalitis and 1,308 
deaths (2). In Europe, the last notable 
outbreak of WNV infection occurred 
in Greece in 2010; 197 persons were 
infected, and 33 died (3). The Czech 
Republic, Denmark, France, and the 
Netherlands reported laboratory-
confi rmed WNV infections in travelers 
returning from North America (1).
We report a case of WNV 
meningoencephalitis in a 28-year-old 
German woman, who sought treatment 
the emergency department of a hospital 
in Potsdam, Germany, on September 7, 
2011. She had a 3-day history of fever 
of up to 40°C and mental confusion. 
Six days before admission, she had 
returned from a 2-week holiday trip 
to Ottawa, Ontario, Canada. She had 
spent most of her time in the city of 
Ottawa.
The patient’s medical history was 
unremarkable. She was in a reduced 
general condition because of a severe 
encephalitic syndrome characterized 
by somnolence, meningism, fever, 
and mental confusion. Laboratory 
investigations revealed leukocytosis 
with 15.000 leukocytes/μL (reference 
range 4,400–11,300 leukocytes/
μL) and elevated C-reactive protein 
of 14.8 mg/L (reference <3 mg/L). 
Cerebrospinal fl uid (CSF) analysis 
on the day of admission showed 
pleocytosis, 430 cells/μL (72% 
granulocytes, 27% lymphocytes. and 
1% monocytes); elevated levels for 
total protein, 1,023 mg/L (reference 
range 150–450 mg/L); an albumin 
level of 637 mg/L (normal range 0–350 
mg/L); and a moderately elevated level 
of the albumin quotient of 20 (reference 
range <6.5). The CSF/serum diagrams 
demonstrated a moderate disturbance of 
the blood–CSF barrier and a substantial 
intrathecal IgM synthesis of 27.6% 
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(6.15 mg/L) but no intrathecal IgA or 
IgG synthesis. Results of magnetic 
resonance imaging of the brain were 
unremarkable. No parenchymal lesions 
were found.
Antimicrobial drug therapy 
was initiated with ceftriaxone and 
ampicillin. Acyclovir was administered 
empirically for herpes simplex 
encephalitis until this diagnosis 
was excluded. Molecular and 
serologic testing of serum and CSF 
samples revealed no acute infection 
with herpesviruses, enteroviruses, 
alphaviruses, orthobunyaviruses, and 
arenaviruses or with mycobacteria, 
Borrelia spp., Toxoplasma gondii, 
Chlamydia spp., Leptospira spp., 
and Mycoplasma pneumoniae. CSF 
and blood cultures were negative 
for fungi and bacteria, including 
mycobacteria. An encephalitic 
syndrome caused by N-methyl-D-
aspartate antibodies was also excluded. 
On the basis of the patient’s travel 
history, the clinical symptoms, and 
the initial laboratory fi ndings, WNV 
infection was suspected. Indirect 
immunofl uorescence assays and virus 
neutralization tests (VNT) for WNV 
and other fl aviviruses were performed 
as described (4). IgM and IgG against 
WNV were detected in serum and in 
CSF by indirect immunofl uorescence 
assay with an 8-fold (IgM) and 32-
fold (IgG) increase in serum titer 
from day 4 to day 26 (Table). WNV 
IgG and WNV IgM titers were higher 
than the titers of antibodies against 
the other fl aviviruses tested (Table), 
indicating that the antibodies resulted 
from a WNV infection. The serologic 
diagnosis was further substantiated 
by detection of WNV neutralizing 
antibodies at day 11(VNT titer 640). 
The VNT titer further increased to 
2,560 on day 26 after onset of disease. 
Results of reverse transcription PCR 
were negative for WNV and members 
of genus Flavivirus in serum and CSF 
samples taken 4 days after disease onset. 
Attempts to isolate WNV from serum 
and CSF samples in cell culture failed 
as well. The patient recovered slowly 
and was discharged from the hospital 
in Potsdam on September 15, 2011. 
She was then referred to a neurologic 
rehabilitation center in Berlin and was 
discharged from there after 2 months 
with a characterization of restitutio ad 
integrum (i.e., full recovery, restoration 
to original condition).
We report a case of WNV 
infection imported into Germany 
that was unambiguously confi rmed 
by laboratory testing. WNV 
meningoencephalitis was diagnosed 
on the basis of strict serologic criteria 
established by the Centers for Disease 
Control and Prevention (Atlanta, GA, 
USA) (5). In 2011, 69 clinical cases of 
WNV infection were reported from the 
province of Ontario, although no cases 
in the city of Ottawa were reported 
(Public Health Agency of Canada; 
www.eidgis.com/wnvmonitorca). This 
imported case adds to these cases and 
suggests that travelers are at risk, even 
if they visit only Ottawa. Physicians in 
Germany should be aware of the risk 
for WNV infection among travelers 
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Table. Results of indirect immunofluorescence assays performed on serum and CSF samples from patient with suspected WNV 
infection, Germany, 2011* 
Virus used as antigen Ig class 
Antibody titer in serum  Antibody titer in CSF 
Day 4 Day 6 Day 11 Day 26 Day 4 Day 6 
WNV IgG 320 1,280 5,120 10,240  20 40 
WNV IgM 160 160 1,280 1,280  10 20 
SLEV IgG 80 80 1,280 2,560  <10 <10 
SLEV IgM 20 20 40 <20  <10 <10 
JEV IgG ND <20 ND 1,280  ND <10 
JEV IgM ND <20 ND <20  ND <10 
DENV IgG ND 80 ND 640  ND <10 
DENV IgM ND 20 ND <20  ND <10 
YFV IgG ND <20 ND ND  ND <10 
YFV IgM ND. <20 ND ND  ND <10 
TBEV IgG ND <20 ND ND  ND <10 
TBEV IgM ND <20 ND ND  ND <10 
*CSF, cerebrospinal fluid; WNV, West Nile virus; SLEV, St. Louis encephalitis virus; JEV, Japanese encephalitis virus; ; ND, not done; DENV, dengue 
virus; YFV, yellow fever virus; TBEV, tick-borne encephalitis virus. Titers <20 for serum and <10 for CSF are considered negative. 
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To the Editor: Scarlet fever is 
a notifi able disease in Hong Kong, 
Guangdong Province, and Macau in 
the People’s Republic of China. All 3 
areas reported substantial increases in 
cases during 2011 (Figure, panel A). In 
Hong Kong, individual data, including 
age, geographic location, date of no-
tifi cation, and travel history within 
the incubation period, were collected 
from all locally notifi ed scarlet fever 
case-patients. As of December 31, 
2011, a total of 1,535 cases (21.7 cas-
es/100,000 population) were reported, 
which was ≈10× higher than the aver-
age number of annual cases reported 
during the preceding 10 years (1). Of 
those, 730 cases were laboratory con-
fi rmed; 46 cases were imported; and 2 
cases, 1 each in a 7-year-old girl and a 
5-year-old boy co-infected with chick-
enpox, resulted in death (2).
Group A Streptococcus (GAS), 
the bacterium that causes scarlet fever, 
is mainly transmitted by direct con-
tact with saliva and nasal fl uids from 
infected persons (3). Many children 
can also carry GAS or be asymptom-
atically infected (4). A recent study in 
China showed that GAS is commonly 
resistant to macrolides and tetracy-
cline but sensitive to penicillin, chlor-
amphenicol, cefradine, and ofl oxacin 
(5). In Hong Kong, GAS emm type 12 
dominated among the isolates cultured 
during 2011 (6). Most of the cases re-
ported were in children <10 years of 
age (range 1 month–51 years; me-
dian 6 years [interquartile range 4–7 
years]). The age distribution is similar 
to that reported during previous years 
(data not shown).
In the United Kingdom during 
the mid-19th century, scarlet fever 
epidemics were found to follow a 5- 
to 6-year cycle, but this pattern disap-
peared as incidence decreased (7). An-
nual scarlet fever notifi cations in Hong 
Kong remained low during 2001–
2010 (<4 cases/100,000 population) 
and did not demonstrate any apparent 
long-term pattern. The recent increase 
in scarlet fever notifi cations might be 
attributable to antigenic drift, increase 
in virulence of GAS (8), or increased 
circulation of GAS. However, other 
than mandatory notifi cation of medi-
cally attended case-patients, system-
atic laboratory testing of GAS isolates 
was not conducted in Hong Kong, and 
these possibilities could not be further 
investigated.
Notifi cations of scarlet fever usu-
ally peak during December–March in 
Hong Kong, but the outbreak in 2011 
peaked in June (Figure, panel B). The 
rise in scarlet fever cases in Guang-
dong Province and Macau slightly 
preceded that in Hong Kong; cases in 
Guangdong peaked in April (Figure, 
panel A). Maximum cross-correlations 
between spline-interpolated weekly 
scarlet fever notifi cations in Guang-
dong and Macau and those in Hong 
Kong were found at 1- and 2-week 
lags, respectively (ρ = 0.45 and 0.58) 
(online Technical Appendix, wwwnc.
cdc.gov/EID/pdfs/12-0062-Techapp.
pdf).
In 2011, scarlet fever notifi cation 
rates were elevated in all 4 regions 
of Hong Kong: New Territories East, 
New Territories West, Kowloon, and 
Hong Kong Island at 27.2, 21.7, 18.9, 
and 19.6 cases per 100,000 popula-
tion, respectively. However, a distinct-
ly higher proportion of imported cases 
before July 2011 (12 of 14, p value for 
exact binomial test = 0.01) were noti-
fi ed in New Territories East and New 
Territories West, where the main bor-
der crossings to mainland China are 
located. This fi nding suggests a link 
to the outbreak in Guangdong in these 
regions during the early phase of the 
local outbreak.
We estimated the instantaneous 
reproduction number (Rt), which 
measures the time-dependent fre-
quency of transmission per single 
primary case (online Technical Ap-
pendix) (9). An Rt consistently >1 
would indicate sustained local trans-
mission. We estimated Rt on the basis 
of the daily scarlet fever notifi cation 
data in different periods, adjusted for 
imported cases. For 19 cases (1.2% 
of all cases), we could not determine 
whether infection was local or im-
ported. We estimated Rt in 2 differ-
ent ways: either by assuming that all 
of these cases were local or by as-
suming that they all were imported, 
to represent possible extreme values 
of Rt. Rt fl uctuated between 0.6 and 
2.0 and was consistently >1 from 
mid-May through the end of June. Rt 
fell quickly to <1 beginning in early 
July after 2 fatal scarlet fever cases 
were reported on May 29 and June 
21, which raised widespread concern 
in the community (Figure, panel C). 
Heightened surveillance, publicity, 
health education to the public (on-
line Technical Appendix) were im-
plemented by the Centre for Health 
Protection in early June and could 
have contributed to the reduction in 
transmissibility. The health education 
measures included guidance on pre-
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